Comparing a new insulin product to the original
This study tests whether a new version of a fast-acting insulin product works the same as the original. It is for healthy people to check safety and how the body handles the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 55.
- Your weight is at least 110 pounds and your body mass index (BMI) is between 19 and 28.
- Your blood sugar levels are normal.
- You are generally healthy with no major medical conditions.
- You have not taken certain medicines or supplements in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This early-stage study tests whether a new oral (swallowed) form of insulin called SCD0503 works as well as regular injected insulin in men with type 1 diabetes. Researchers will also check how food affects how your body absorbs the oral insulin.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
This study tests an insulin capsule in healthy young men to see how well it works compared to standard insulin. It may lead to an easier way to take insulin for diabetes.
Hear when a new Pharmacokinetics and Pharmacodynamics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.